Autopsy report · NCT00810212
Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion
Cause of deathOther
“Sponsor preferred a better study design”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1, Phase 2
- Sponsor
- Mesoblast, Ltd.
- Sponsor type
- Industry
- Conditions
- Degenerative Disc Disease; Degenerative Spondylolisthesis; Spinal Stenosis
- Interventions
- PLF with autograft; PLF with NeoFuse; PLF with NeoFuse; PLF with NeoFuse
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
“Sponsor has designed another study with different endpoint to replace the current study” - Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses
“New study design will be made” - AndraTec PMCF Study : Investigating the AndraTec Guidewires,PTA Balloons and Stents in Iliac Disease.
“Sponsor did not pusue with the study” - Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
“Study was stopped by the Sponsor” - A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
“Decision to change the study design”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.